Here begins the text.

The 3rd Vietnam-Japan Symposium

November 15, 2022
Pharmaceuticals and Medical Devices Agency

Purpose

 Globalization of research and development, manufacturing and marketing of medical products has progressed, and cooperation in regulatory activities amongst regulatory agencies has become inevitably important. As the Asian region becomes significant in the area of clinical development and manufacturing of medical products today, PMDA strives to strengthen the collaborative relationship with the Asian regulatory agencies.
 This is the joint conference with an aim to enhance Vietnam and Japan’s mutual understanding of regulatory systems to pursue more effective and efficient pharmaceutical regulations.
 This symposium will offer presentations with our latest information and discussions from the pharmaceutical regulatory perspective in the area of Actions for COVID-19 by regulatory authorities, Digitalization in drug review system, International collaboration to provide products satisfied with patients’ needs in Asia.

Host

Pharmaceuticals and Medical Devices Agency (PMDA)
The Drug Administration Department of Vietnam (DAV)


Support

Japan Pharmaceutical Manufacturers Association (JPMA)
The Japanese Chamber of Commerce and Industry in Vietnam (JCCI), Japanese Pharmaceutical Association in Vietnam (JPAV)

1. Date

29 Nov, 2022 (Tuesday)

2. Venue

The symposium will be held by virtual (Zoom).
Participants will receive the link by email. 

3. Registration

  • There is no registration fee for this symposium.
  • Please register through the following website.
         https://form.qooker.jp/Q/auto/ja/Registration/enroll/
  • When the number of participants reaches the prearranged capacity.
  • Please ask International Affairs Committee, JPMA about registration.

4. Interpretation

(TBD)

5. Agenda

Please see attached for the details of the program.

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.